Condition
Stroke (in Patients With Atrial Fibrillation) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Stroke (in Patients With Atrial Fibrillation) clinical trials that are recruiting, at sites in 5 countries (most in Denmark (3), Norway (1), Sweden (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Stroke (in Patients With Atrial Fibrillation) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Left atrial appendage closure with AtriLASH Seralene suture during cardiac surgery for atrial fibrillation | — | Kamenitz, Vojvodina | Recruiting | Jan 22, 2026 |
| Assessing stroke risk in patients with newly diagnosed atrial fibrillation | — | Esbjerg, Region Syddanmark | Recruiting | Apr 29, 2025 |
| Thrombolysis for stroke patients on Factor Xa inhibitors | Phase 3 | Aalborg, Aalborg and 20 other locations | Recruiting | Mar 14, 2025 |
| Heat shock protein 47 in blood clot conditions | — | Aarhus, Central Region and 1 other locations | Recruiting | Dec 12, 2024 |
All recruiting trials (4)
-
Left atrial appendage closure with AtriLASH Seralene suture during cardiac surgery for atrial fibrillation
This trial tests whether closing the left atrial appendage with the AtriLASH Seralene hemostatic suture during cardiac surgery can reduce stroke risk in adults with atrial fibrillation.
-
Assessing stroke risk in patients with newly diagnosed atrial fibrillation
This study is testing how to identify stroke risk in people who have just been diagnosed with atrial fibrillation to see who might need blood-thinning medication to prevent strokes.
-
Thrombolysis for stroke patients on Factor Xa inhibitors
This study is testing if a common stroke treatment can safely help patients who have taken certain blood thinners in the last two days.
-
Heat shock protein 47 in blood clot conditions
This will test whether platelet levels of Heat Shock Protein 47 (HSP47) can help predict outcomes in adults with recent venous thromboembolism, ST-elevation myocardial infarction, or ischemic stroke compared with healthy volunteers.
Related topics
Quick answers
How many Stroke (in Patients With Atrial Fibrillation) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Denmark (3 trials), Norway (1 trial), Sweden (1 trial), Serbia (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.